首页> 美国卫生研究院文献>other >Self-Nanoemulsifying Drug Delivery System of Tetrandrine for Improved Bioavailability: Physicochemical Characterization and Pharmacokinetic Study
【2h】

Self-Nanoemulsifying Drug Delivery System of Tetrandrine for Improved Bioavailability: Physicochemical Characterization and Pharmacokinetic Study

机译:粉防己碱的自纳米乳化递药系统用于改善生物利用度:物理化学表征和药代动力学研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The main purpose of this study was to investigate the potential of self-nanoemulsified drug delivery system (SNEDDS) to improve the oral bioavailability of tetrandrine (Tet). SNEDDS was developed by using rational blends of excipients with good solubilizing ability for Tet which was selected based on solubility studies. Further ternary phase diagram was constructed to determine the self-emulsifying region. The optimal formulation with the best self-nanoemulsified and solubilization ability consisted of 40% (w/w) oleic acid as oil, 15% (w/w) SPC and 30% (w/w) Cremophor RH-40 as surfactant, and 15% (w/w) PEG400 as cosurfactant. The average droplet size and zeta-potential of the optimal Tet SNEDDS were 19.75±0.37 nm and 1.87±0.26 mv, respectively. The dissolute rate of Tet SNEDDS in various dissolution media was remarkably faster than Tet commercial tablet. Moreover, in vivo pharmacokinetic study results show that significant increase (p≤ 0.05) in the peak concentration (Cmax) and the area under the curve (AUC) of Tet was observed after the oral administration of Tet SNEDDS and the absorption of Tet from SNEDDS resulted in approximately 2.33-fold increase in oral bioavailability compared with the commercial tablet. Our research suggests that the prepared Tet SNEDDS could be a good candidate for improved the dissolution and oral bioavailability of Tet.
机译:这项研究的主要目的是研究自我纳米乳化药物递送系统(SNEDDS)改善粉防己碱(Tet)的口服生物利用度的潜力。 SNEDDS是通过使用对Tet有良好溶解能力的赋形剂合理混合而开发的,该赋形剂是根据溶解度研究选择的。进一步构建三元相图以确定自乳化区。具有最佳自纳米乳化和增溶能力的最佳配方包括40%(w / w)油酸为油,15%(w / w)SPC和30%(w / w)Cremophor RH-40作为表面活性剂,以及15%(w / w)PEG400作为辅助表面活性剂。最佳的Tet SNEDDS的平均液滴尺寸和ζ电位分别为19.75±0.37 nm和1.87±0.26 mv。 Tet SNEDDS在各种溶出介质中的溶出速率比Tet商用片剂明显更快。此外,体内药代动力学研究结果表明,口服Tet SNEDDS以及Tet从SNEDDS吸收后,观察到Tet的峰值浓度(Cmax)和曲线下面积(AUC)明显增加(p≤0.05)。与市售片剂相比,可导致口服生物利用度提高约2.33倍。我们的研究表明,制备的Tet SNEDDS可能是改善Tet溶出度和口服生物利用度的良好候选者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号